• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Mydecine Innovations Group Inc.

    Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers CSE:MYCO MYCOF
    Mydecine Provides Q4 2023 Business Update
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers CSE:MYCO MYCOF
    Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Announces Conditional Approval of CSE Listing
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Reports its 2023 Annual General Shareholders' Meeting Results
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Innovations Group Provides Corporate Update
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Reports Financial Results for the Year Ended December 2022
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers CSE:NARA MYCOF
    Mydecine Reports Financial Results for the Third Quarter of Fiscal Year 2022
    From Mydecine Innovations Group Inc.
    Via GlobeNewswire
    Tickers MYCOF
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.